AU2002340010A1 - Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors - Google Patents
Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitorsInfo
- Publication number
- AU2002340010A1 AU2002340010A1 AU2002340010A AU2002340010A AU2002340010A1 AU 2002340010 A1 AU2002340010 A1 AU 2002340010A1 AU 2002340010 A AU2002340010 A AU 2002340010A AU 2002340010 A AU2002340010 A AU 2002340010A AU 2002340010 A1 AU2002340010 A1 AU 2002340010A1
- Authority
- AU
- Australia
- Prior art keywords
- indazoles
- substituted
- lyase inhibitors
- pyridyl indoles
- indoles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32499301P | 2001-09-26 | 2001-09-26 | |
US60/324,993 | 2001-09-26 | ||
PCT/US2002/030482 WO2003027094A2 (en) | 2001-09-26 | 2002-09-26 | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002340010A1 true AU2002340010A1 (en) | 2003-04-07 |
Family
ID=23265979
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002362603A Abandoned AU2002362603A1 (en) | 2001-09-26 | 2002-09-26 | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
AU2002340010A Abandoned AU2002340010A1 (en) | 2001-09-26 | 2002-09-26 | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002362603A Abandoned AU2002362603A1 (en) | 2001-09-26 | 2002-09-26 | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1432706A2 (en) |
JP (2) | JP2005528325A (en) |
AU (2) | AU2002362603A1 (en) |
CA (2) | CA2461363A1 (en) |
WO (8) | WO2003027101A1 (en) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60139639D1 (en) * | 2000-12-08 | 2009-10-01 | Takeda Pharmaceutical | SUBSTITUTED THIAZONE DERIVATIVES WITH 3-PYRIDYL GROUPS, PROCESS FOR THEIR PREPARATION AND THEIR USE |
JP4160295B2 (en) * | 2000-12-08 | 2008-10-01 | 武田薬品工業株式会社 | Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof |
US20040147561A1 (en) * | 2002-12-27 | 2004-07-29 | Wenge Zhong | Pyrid-2-one derivatives and methods of use |
BRPI0410348A (en) * | 2003-05-14 | 2006-05-30 | Torreypines Therapeutics Inc | compounds and uses thereof in amyloid-beta modulation |
ES2222827B1 (en) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | DERIVATIVES OF 5-INDOLILSULFONAMIDS, ITS PREPARATION AND ITS APPLICATION AS MEDICINES. |
CA2545719A1 (en) * | 2003-11-14 | 2005-06-02 | Vertex Pharmaceuticals Incorporated | Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
AU2005232745A1 (en) | 2004-04-13 | 2005-10-27 | Astellas Pharma Inc. | Polycyclic pyrimidines as potassium ion channel modulators |
JP4602686B2 (en) * | 2004-04-15 | 2010-12-22 | 広栄化学工業株式会社 | Process for producing 2,6-dihalogeno-4-arylpyridines |
BRPI0516110A (en) | 2004-10-13 | 2008-08-26 | Ptc Therapeutics Inc | senseless suppression compounds and methods for their use |
US7956191B2 (en) * | 2004-10-20 | 2011-06-07 | Merck Serono Sa | 3-arylamino pyridine derivatives |
WO2006051723A1 (en) * | 2004-11-09 | 2006-05-18 | Kaneka Corporation | Method for producing 1-halo-3-aryl-2-propanone |
GB0428514D0 (en) * | 2004-12-31 | 2005-02-09 | Prosidion Ltd | Compounds |
DE602005026867D1 (en) * | 2005-01-19 | 2011-04-21 | Biolipox Ab | INFLAMMATORY INDOL DERIVATIVES |
AP2358A (en) | 2005-05-09 | 2012-01-30 | Achillion Pharmaceuticals Inc | Thiazole compounds and methods of use. |
WO2007016979A2 (en) * | 2005-07-29 | 2007-02-15 | 4Sc Ag | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
FR2889526B1 (en) * | 2005-08-04 | 2012-02-17 | Aventis Pharma Sa | SUBSTITUTED 7-AZA-INDAZOLES, COMPOSITIONS CONTAINING SAME, PROCESS FOR PRODUCTION AND USE |
JPWO2007043401A1 (en) * | 2005-10-07 | 2009-04-16 | キッセイ薬品工業株式会社 | Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same |
TWI385169B (en) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | Heterocyclic substituted pyridine derivatives and antifungal agent containing same |
US20090253687A1 (en) * | 2005-12-28 | 2009-10-08 | Shoji Fukumoto | Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands |
US7645773B2 (en) | 2006-01-18 | 2010-01-12 | Hoffmann-La Roche Inc. | Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase |
CN101374808B (en) | 2006-01-24 | 2011-05-25 | 伊莱利利公司 | Indole sulfonamide modulators of progesterone receptors |
PL2001849T3 (en) * | 2006-03-29 | 2015-04-30 | Hoffmann La Roche | Pyridine and pyrimidine derivatives as mglur2 antagonists |
US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
US7649007B2 (en) | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
US7618989B2 (en) | 2006-08-15 | 2009-11-17 | Wyeth | Tricyclic oxazolidone derivatives useful as PR modulators |
WO2008021309A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
ATE534642T1 (en) * | 2006-09-21 | 2011-12-15 | Eisai R&D Man Co Ltd | PYRIDINE DERIVATIVE SUBSTITUTED BY A HETEROARYL RING AND ANTIFUNGAL AGENT CONTAINING SAME |
WO2008035726A1 (en) | 2006-09-21 | 2008-03-27 | Eisai R & D Management Co., Ltd. | Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
EP2076265A4 (en) | 2006-10-02 | 2010-09-22 | Cortendo Invest Ab | Ketoconazole enantiomer in humans |
US8466154B2 (en) | 2006-10-27 | 2013-06-18 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to wrapping of dehydrons |
US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
JP2010528019A (en) | 2007-05-22 | 2010-08-19 | アキリオン ファーマシューティカルズ,インコーポレーテッド | Heteroaryl substituted thiazole |
AR068193A1 (en) | 2007-08-13 | 2009-11-11 | Divergence Inc | COMPOSITIONS AND METHODS TO CONTROL NEMATODES |
SI2195312T1 (en) | 2007-10-09 | 2013-01-31 | Merck Patent Gmbh | Pyridine derivatives useful as glucokinase activators |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
ES2442930T3 (en) * | 2008-01-11 | 2014-02-14 | Novartis Ag | Pyrimidines as kinase inhibitors |
EP2250160B1 (en) | 2008-01-25 | 2015-11-11 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
EP2250998B1 (en) | 2008-02-08 | 2016-04-13 | Shiseido Company, Ltd. | Skin whitening agent and external preparation for the skin |
US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
PT2959900T (en) * | 2008-06-16 | 2017-06-22 | Univ Tennessee Res Found | Compound for treatment of cancer |
US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
EP2326627A1 (en) * | 2008-08-20 | 2011-06-01 | Schering Corporation | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
PE20110843A1 (en) | 2008-09-22 | 2011-12-08 | Cayman Chem Co | DERIVATIVES OF 5- (1H-IMIDAZOL-5-IL) -2-PHENYLPYRIMIDINE, AS INHIBITORS OF PROSTAGLANDIN D HEMATOPOYETIC SYNTHASE |
US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
CA2750935A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
JP2012520859A (en) * | 2009-03-19 | 2012-09-10 | サノフイ | SHP90 inhibitory indazole derivatives, compositions containing them, and uses thereof |
WO2011059784A1 (en) * | 2009-10-29 | 2011-05-19 | Bristol-Myers Squibb Company | Tricyclic heterocyclic compounds |
WO2011051198A2 (en) * | 2009-10-30 | 2011-05-05 | Bayer Cropscience Ag | Pyridine derivatives as agricultural pesticides |
DE102009058280A1 (en) | 2009-12-14 | 2011-06-16 | Merck Patent Gmbh | thiazole |
MX2012010115A (en) | 2010-03-01 | 2013-02-26 | Gtx Inc | Compounds for treatment of cancer. |
JP2013534539A (en) | 2010-07-15 | 2013-09-05 | ブリストル−マイヤーズ スクイブ カンパニー | Azaindazole compounds |
WO2012018948A2 (en) | 2010-08-04 | 2012-02-09 | Pellficure Pharmaceuticals, Inc. | Novel treatment of prostate carcinoma |
US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
EP2603216A4 (en) | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | Heteroaryls and uses thereof |
MA34797B1 (en) | 2010-08-11 | 2014-01-02 | Millennium Pharm Inc | HETEROARYLES AND THEIR USES |
EP2627181A4 (en) | 2010-10-13 | 2014-03-19 | Millennium Pharm Inc | Heteroaryls and uses thereof |
JP5953308B2 (en) * | 2010-10-22 | 2016-07-20 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | New heterocyclic compounds as pesticides |
CA2816088A1 (en) * | 2010-10-28 | 2012-05-03 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
JP2013542259A (en) | 2010-11-12 | 2013-11-21 | ブリストル−マイヤーズ スクイブ カンパニー | Substituted azaindazole compounds |
GB2485404A (en) * | 2010-11-15 | 2012-05-16 | Nat Univ Ireland | Metal-complexed pyridyl-substituted tetrazole compounds and their use in treating cancer |
CN102675286B (en) * | 2011-03-07 | 2015-08-19 | 中国科学院上海药物研究所 | One class indazole compounds and preparation method thereof, purposes and pharmaceutical composition |
ES2656218T3 (en) | 2011-04-28 | 2018-02-26 | Novartis Ag | 17 alpha-hydroxylase / C17,20-lyase inhibitors |
US20120302573A1 (en) * | 2011-05-25 | 2012-11-29 | Paul Francis Jackson | Methods of inhibiting pro matrix metalloproteinase activation |
WO2013049263A1 (en) | 2011-09-27 | 2013-04-04 | Bristol-Myers Squibb Company | Substituted bicyclic heteroaryl compounds |
WO2014055595A1 (en) | 2012-10-05 | 2014-04-10 | Merck Sharp & Dohme Corp. | Indoline compounds as aldosterone synthase inhibitiors related applications |
EP2934144B1 (en) * | 2012-12-20 | 2017-07-19 | Merck Sharp & Dohme Corp. | Indazole compounds as aldosterone synthase inhibitors |
CN109568312A (en) | 2013-03-05 | 2019-04-05 | 田纳西大学研究基金会 | Compound for treating cancer |
AU2014241816B9 (en) | 2013-03-14 | 2019-02-14 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
WO2016040896A1 (en) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
CA3044812A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione |
JP7193071B2 (en) * | 2017-02-08 | 2022-12-20 | 国立大学法人東海国立大学機構 | Fluorescent materials and UV absorbers |
WO2021126779A1 (en) * | 2019-12-18 | 2021-06-24 | The Regents Of The University Of California | Inhibitors of lin28 and methods of use thereof |
US20210246109A1 (en) * | 2020-02-11 | 2021-08-12 | University Of Kentucky Research Foundation | Potent and selective inhibitors of cytochrome p450 |
WO2023049199A1 (en) * | 2021-09-24 | 2023-03-30 | Zeno Management, Inc. | Azole compounds |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK150068C (en) * | 1978-06-02 | 1987-06-29 | Pfizer | METHOD OF ANALOGUE FOR THE PREPARATION OF AMINOTHIAZOLES |
JPS55133366A (en) * | 1979-04-05 | 1980-10-17 | Otsuka Pharmaceut Factory Inc | Thiazole derivative |
US4536505A (en) * | 1983-05-17 | 1985-08-20 | Ciba-Geigy Corporation | Certain N-(pyridyl) indoles |
DE3940476A1 (en) * | 1989-12-07 | 1991-06-13 | Bayer Ag | PYRIDINYLPYRIMIDINE DERIVATIVES |
DE3940477A1 (en) * | 1989-12-07 | 1991-06-13 | Bayer Ag | HETARYL-SUBSTITUTED PYRIDINYLPYRIMIDINE DERIVATIVES |
JPH04154773A (en) * | 1990-10-15 | 1992-05-27 | Green Cross Corp:The | Thiazole derivative |
DE4117560A1 (en) * | 1991-05-29 | 1992-12-03 | Bayer Ag | USE OF PYRIDINYLPYRIMIDINE DERIVATIVES TO PROTECT TECHNICAL MATERIALS |
TW223004B (en) * | 1991-11-25 | 1994-05-01 | Sumitomo Chemical Co | |
US5395817A (en) * | 1992-01-22 | 1995-03-07 | Imperial Chemical Industries Plc | N-arylindoles and their use as herbicides |
US5599774A (en) * | 1992-01-22 | 1997-02-04 | Imperial Chemical Industries Plc | N-arylindoles and their use as herbicides |
US5444038A (en) * | 1992-03-09 | 1995-08-22 | Zeneca Limited | Arylindazoles and their use as herbicides |
JPH07508259A (en) * | 1992-03-09 | 1995-09-14 | ゼネカ リミテッド | Novel arylindazoles and their use as herbicides |
US5856347A (en) * | 1994-11-29 | 1999-01-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof |
US6046136A (en) * | 1997-06-24 | 2000-04-04 | Zeneca Limited | Herbicidal heterocyclic N-oxides compounds |
US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
EP1019399A1 (en) * | 1997-10-03 | 2000-07-19 | Merck Frosst Canada & Co. | Aryl thiophene derivatives as pde iv inhibitors |
CA2331118A1 (en) * | 1998-05-12 | 1999-11-18 | Wyeth | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
WO2000006556A1 (en) * | 1998-07-27 | 2000-02-10 | Abbott Laboratories | Substituted oxazolines as antiproliferative agents |
DE60136530D1 (en) * | 2000-03-01 | 2008-12-24 | Janssen Pharmaceutica Nv | 2,4-DISUBSTITUTED THIAZOLYL DERIVATIVES |
-
2002
- 2002-09-26 WO PCT/US2002/030979 patent/WO2003027101A1/en not_active Application Discontinuation
- 2002-09-26 EP EP02799636A patent/EP1432706A2/en not_active Withdrawn
- 2002-09-26 AU AU2002362603A patent/AU2002362603A1/en not_active Abandoned
- 2002-09-26 EP EP02778338A patent/EP1432698A2/en not_active Withdrawn
- 2002-09-26 WO PCT/US2002/030482 patent/WO2003027094A2/en not_active Application Discontinuation
- 2002-09-26 JP JP2003530682A patent/JP2005528325A/en not_active Withdrawn
- 2002-09-26 CA CA002461363A patent/CA2461363A1/en not_active Abandoned
- 2002-09-26 WO PCT/US2002/030834 patent/WO2003027107A1/en not_active Application Discontinuation
- 2002-09-26 JP JP2003530675A patent/JP2005532983A/en not_active Withdrawn
- 2002-09-26 CA CA002461360A patent/CA2461360A1/en not_active Abandoned
- 2002-09-26 WO PCT/US2002/030982 patent/WO2003027095A1/en not_active Application Discontinuation
- 2002-09-26 AU AU2002340010A patent/AU2002340010A1/en not_active Abandoned
- 2002-09-26 WO PCT/US2002/030483 patent/WO2003027085A2/en not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030924 patent/WO2003027100A1/en not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030981 patent/WO2003027105A1/en not_active Application Discontinuation
- 2002-09-26 WO PCT/US2002/030983 patent/WO2003027096A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003027094A2 (en) | 2003-04-03 |
WO2003027101A1 (en) | 2003-04-03 |
CA2461360A1 (en) | 2003-04-03 |
WO2003027095A1 (en) | 2003-04-03 |
WO2003027085A3 (en) | 2003-12-04 |
EP1432698A2 (en) | 2004-06-30 |
WO2003027094A3 (en) | 2003-10-23 |
WO2003027096A1 (en) | 2003-04-03 |
AU2002362603A1 (en) | 2003-04-07 |
WO2003027107A1 (en) | 2003-04-03 |
JP2005532983A (en) | 2005-11-04 |
CA2461363A1 (en) | 2003-04-03 |
WO2003027100A1 (en) | 2003-04-03 |
EP1432706A2 (en) | 2004-06-30 |
WO2003027105A1 (en) | 2003-04-03 |
JP2005528325A (en) | 2005-09-22 |
WO2003027085A2 (en) | 2003-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002340010A1 (en) | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | |
AU2002362895A1 (en) | 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors | |
AU2002346929A1 (en) | 5-acylamino-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors | |
AP2003002857A0 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors. | |
MXPA03006260A (en) | Substituted amine derivatives and methods of use. | |
AU2002303892A1 (en) | 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors | |
AU2002213336A1 (en) | Substituted heterocyclic compounds for treating multidrug resistance | |
AU2001274009A1 (en) | Substituted indoles as parp inhibitors | |
AU2001269939A1 (en) | Methods for eliminating the formation of biofilm | |
HUP0500111A3 (en) | Indolinone derivatives useful as protein kinase inhibitors | |
AU2002226911A1 (en) | Indol derivative and their use as inhibitors of p38 kinase | |
AU2002357003A1 (en) | Indoles as naaladase inhibitors | |
AU2002361861A1 (en) | SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF | |
IL154343A0 (en) | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors | |
AU2001231664A1 (en) | Indol-3-yl derivatives | |
AU5215700A (en) | Substituted indolinone as tyrosine kinase inhibitors | |
ZA200307306B (en) | Indolines, substituted in portion 6, and their use as kinase inhibitors. | |
PL369850A1 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
AU2002230056A1 (en) | Indole derivatives and their uses as heparanase inhibitors | |
AU2001266648A1 (en) | Kits and methods for optimizing the efficacy of chondroprotective compositions | |
AU2003261099A1 (en) | 4,7-disubstituted indoles and methods of making | |
AU2002334728A1 (en) | Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors | |
AU2002213830A1 (en) | The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache | |
AU2002334730A1 (en) | Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors | |
AU2002327756A1 (en) | Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |